This is a "connection" page, showing publications co-authored by Russell Norris and Thomas Dix.
Connection Strength

  1. Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs. Molecules. 2022 Jun 08; 27(12).
    View in: PubMed
    Score: 0.222
  2. Biased Opioid Receptor Ligands: Gain without Pain. Trends Endocrinol Metab. 2020 11; 31(11):801-802.
    View in: PubMed
    Score: 0.197
  3. The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine. Front Pharmacol. 2020; 11:1253.
    View in: PubMed
    Score: 0.196
  4. Developmental basis for filamin-A-associated myxomatous mitral valve disease. Cardiovasc Res. 2012 Oct 01; 96(1):109-19.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.